8
landing page
FasterCures and COVID-19
Ending the Crisis
The goal of FasterCures is to understand how industry and government are working
to end the COVID-19 crisis. To help us in this mission, we have created Four Pillars., FasterCures: COVID-19 Action Recommendations
Learn More About the Recommendations
+ Read More
panel
FasterCures Roundtable (Invite only)
As health systems worldwide recover and rebuild in the retention wake of COVID-19, the importanc
e of early preparation, multi-stakeholder collaboration, and constant innovation must not be forgotten.
+ Read More
report
A Call to Action for Health Equity: Solutions from the Front Lines for Local and National Efforts
FasterCures is advancing system change within biomedical research to focus on and value diversity a
nd representation within clinical trials and the workforce.
+ Read More
article
FasterCures mobilizes for next phase of work to save lives by improving the global medical R&D system, launches health data initiative
WASHINGTON, October 22, 2018 – FasterCures, the Milken Institute center whose mission is to save liv
es by speeding medical breakthroughs to patients, is announcing new initiatives to engage the private sector, strengthen global partnerships and harness
+ Read More
video
A Conversation with Scott Gottlieb, Commissioner, U.S. Food and Drug Administration
This closing session will begin with a conversation with Scott Gottlieb, Commissioner, U.S. Food a
nd Drug Administration, moderated by FasterCures' Tanisha Carino.
+ Read More
video
Advances in Science: Beyond “One Disease at a Time:” Therapeutic Platforms for Monogenic Disease
Guest speaker Philip John (P.J.) Brooks, PhD, acting director of the Division of Rare Diseases Res
earch Innovation at the National Institutes of Health’s National Center for Advancing Translational Sciences (NCATS) delivered a presentation about cell an
+ Read More
video
System Thinking to Drive Patient Engagement: Walking the Talk
The first chief patient officer role was created in 2014, and since then, biopharmaceutical compan
ies have created similar positions, restructured teams, and convened internal meetings to advance patient engagement and patient-centered practices through
+ Read More
article
Letter of Support: Reauthorization of Food and Drug Administration (FDA) User Fee Programs
Submitted electronically